Stock News - Ultragenyx Pharmaceutical Inc. $RARE
Latest Stock News for $RARE
Ultragenyx Pharmaceutical Receives FDA Acceptance for UX111 Gene Therapy Review
Expected Stock impact: Very Positive
2026-04-02 12:46:18
Ultragenyx Pharmaceutical Receives FDA Clearance for UX016 IND Application
Expected Stock impact: Very Positive
2026-03-30 12:47:06
Ultragenyx Pharmaceutical Reports Positive Phase 3 Results for DTX301 in OTC Deficiency
Expected Stock impact: Very Positive
2026-03-12 16:46:27
